Hepatocystin Is not secreted in cyst fluid of hepatocystin mutant polycystic liver patients

Journal of Proteome Research

Volumn 7, Issue 6, 2008, Pages 2490-2495

  Waanders, Esmé ^a   Lameris, Anke L L ^a   Den Camp, Huub J M OP ^b   Pluk, Wendy ^a   Gloerich, Jolein ^a   Strijk, Simon P ^a   Drenth, Joost P H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Hepatocystin; Liver cyst fluid; MALDI TOF; MS; NLC MS MS; PCLD; PRKCSH; Protein profile

Indexed keywords

GENE PRODUCT; HEPATOCYSTIN; MUTANT PROTEIN; UNCLASSIFIED DRUG; GLUCOSIDASE; PLASMA PROTEIN; PRKCSH PROTEIN, HUMAN; SERUM ALBUMIN; SIGNAL PEPTIDE;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; AUTOCRINE EFFECT; BASOLATERAL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CYST FLUID; FEMALE; GENE; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; LIVER POLYCYSTIC DISEASE; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PRKCSH GENE; PROTEIN SECRETION; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMISTRY; CYST; DOG; GENETICS; LIVER DISEASE; METABOLISM; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; SECRETION; TANDEM MASS SPECTROMETRY;

ANIMALS; BLOOD PROTEINS; CELL LINE; CYST FLUID; CYSTS; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GLUCOSIDASES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER DISEASES; MALE; MUTATION; SERUM ALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TRANSFECTION;

EID: 49849092060     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8000282     Document Type: Article

References (25)

1. Qian, Q.; Li, A.; King, B. F.; Kamath, P. S.; Lager, D. J.; Huston, J.; Shub, C; Davila, S.; Somlo, S.; Torres, V. E. Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003, 37 (1), 164-171.
2. Gabow, P. A.; Johnson, A. M.; Kaehny, W. D.; Manco-Johnson, M. L.; Duley, I. T.; Everson, G. T. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990, 11 (6), 1033-1037.
3. Drenth, J. P.; Te Morsche, R. H.; Smink, R.; Bonifacino, I. S.; Jansen, J. B. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat. Genet. 2003, 33 (3), 345- 347.
4. Li, A.; Davila, S.; Furu, L.; Qian, Q.; Tian, X.; Kamath, P. S.; King, B. F.; Torres, V. E.; Somlo, S. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am. J. Hum. Genet. 2003, 72 (3), 691-703.
5. Trombetta, E. S.; Fleming, K. G.; Helenius, A. Quaternary and domain structure of glycoprotein processing glucosidase II. Biochemistry 2001, 40 (35), 10717-10722.
6. Drenth, J. P.; Martina, J. A.; van de, Kerkhof, R.; Bonifacino, J. S.; Jansen, J. B. Polycystic liver disease is a disorder of cotranslational protein processing. Trends Mol. Med. 2005, 11 (1), 37-42.
7. Drenth, J. P.; Martina, J. A.; Te Morsche, R. H.; Jansen, J. B.; Bonifacino, J. S. Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease. Gastroenterology 2004, 126 (7), 1819-1827.
8. Ravine, D.; Gibson, R. N.; Walker, R. G.; Sheffield, L. J.; Kincaid- Smith, P.; Danks, D. M. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994, 343 (8901), 824-827.
9. Waanders, E.; Te Morsche, R. H.; de Man, R. A.; Jansen, J. B.; Drenth, J. P. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease. Hum. Mutat. 2006, 27 (8), 830.
10. Pappin, D. J.; Hojrup, P.; Bleasby, A. J. Rapid identification of proteins by peptide-mass fingerprinting. Curr. Biol. 1993, 3 (6), 327-332.
11. Ochs, D. Protein contaminants of sodium dodecyl sulfate-poly-acrylamide gels. Anal. Biochem. 1983, 135 (2), 470-474.
12. Rappsilber, J.; Friesen, W. J.; Paushkin, S.; Dreyfuss, G.; Mann, M. Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode. Anal. Chem. 2003, 75 (13), 3107-3114.
13. Weatherly, D. B.; Astwood, J. A.; Minning, T. A.; Cavola, C; Tarleton, R. L.; Orlando, R. A Heuristic method for assigning a false-discovery rate for protein identifications from Mascot database search results. Mol. Cell. Proteomics 2005, 4 (6), 762-772.
14. Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; Butler, H.; Cherry, J. M.; Davis, A. P.; Dolinski, K.; Dwight, S. S.; Eppig, J. T.; Harris, M. A.; Hill, D. P.; Issel-Tarver, L.; Kasarskis, A.; Lewis, S.; Matese, J. C; Richardson, J. E.; Ringwald, M.; Rubin, G. M.; Sherlock, G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25 (1), 25-29.
15. Waanders, E.; Croes, H. J.; Maass, C. N.; Te Morsche, R. H.; van Geffen, H. J.; van Krieken, J. H.; Fransen, J. A.; Drenth, J. P. Cysts of PRKCSH mutated polycystic liver disease patients lack hepa- tocystin but express Sec63p. Histochem. Cell Biol. 2008, 129 (3), 301-310.
16. Weischenfeldt, J.; Lykke-Andersen, J.; Porse, B. Messenger RNA surveillance: neutralizing natural nonsense. Curr. Biol. 2005, 15 (14), R559-R562.
17. Patterson, M.; Gonzalez-Vitale, J. C; Fagan, C. J. Polycystic liver disease: a study of cyst fluid constituents. Hepatology 1982, 2 (4), 475-478.
18. Li, A.; Dubey, S.; Varney, M. L.; Dave, B. J.; Singh, R. K. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix met- alloproteinases production and regulated angiogenesis. J. Immunol. 2003, 170 (6), 3369-3376.
19. Munemura, C; Uemasu, J.; Kawasaki, H. Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: possible evidence of heterogeneity in cystogenesis. Am. J. Kidney Dis. 1994, 24 (4), 561-568.
20. Nichols, M. T.; Gidey, E.; Matzakos, T.; Dahl, R.; Stiegmann, G.; Shah, R. J.; Grantham, J. J.; Fitz, J. G.; Doctor, R. B. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology 2004, 40 (4), 836-846.
21. Slade, M. J.; Kirby, R. B.; Pocsi, I.; Jones, J. K.; Price, R. G. Presence of laminin fragments in cyst fluid from patients with autosomal dominant polycystic kidney disease (ADPKD): role in proliferation of tubular epithelial cells. Biochim. Biophys. Acta 1998, 1401 (2), 203-210.
22. Ye, M.; Grant, M.; Sharma, M.; Elzinga, L.; Swan, S.; Torres, V. E.; Grantham, J. J. Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. J. Am. Soc. Nephrol. 1992, 3 (4), 984-994.
23. Grantham, J. J.; Ye, M.; Davidow, C; Holub, B.; Sharma, M. Evidence for a potent lipid secretagogue in the cyst fluids of patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 1995, 6 (4), 1242-1249.
24. Mangoo-Karim, R.; Uchic, M. E.; Grant, M.; Shumate, W. A.; Calvet, J. P.; Park, C. H.; Grantham, J. J. Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J. 1989, 3 (14), 2629-2632.
25. Masyuk, T. V.; Masyuk, A. I.; Torres, V. E.; Harris, P. C; Larusso, N. F. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′,5′-cyclic monophosphate. Gastroenterology 2007, 132 (3), 1104-1116.